Tofflon focuses on studying drug manufacturing science and process equipment manufacturing science, and practices drug process knowledge integration with pharma equipment knowledge. Taking the “Synergy Global Advanced Technologies” strategy, Tofflon built a comprehensive development institute in Shanghai headquarters, built design houses and technical centers in the USA, Europe, and India, and established joint ventures and technology collaborations with technical partners from the USA, Europe, and Japan. Furthermore, Tofflon has built six modern pharmaceutical equipment manufacturing bases with global competitiveness. It has been approved for all international regulatory certifications, such as German TUV ISO9001, ISO14001, OHSAS18001, CE, UL, PED, ASME, etc. Thanks to 5000+ Chinese and foreign employees, Tofflon can provide competitive pharmaceutical equipment and system solutions valuable for competence improvement of the pharma and biotech companies.

For the mission of “Expertise in Biopharmaceutical”, Tofflon will continuously work with the biopharmaceutical industry to face and meet the challenges and pressures in the industry through developing “innovative drug manufacturing science” and building an “advanced drug manufacturing platform”. In the coming years, Tofflon will dedicate itself to growing from “China Tofflon to Global Tofflon”, from “Equipment Supplier to Solution Provider” to grow up to a total solution provider of pharmaceutical manufacturing systems and engineering for the global pharma and biotech industry to contribute to the maximum benefits and welfare of its served society, customers, stockholders, employees, and their families.